Table 1.
Patient characteristics
| ARH (N = 142) | RRH1 (‘06–'12) (N = 77) | RRH2 (‘13–'18) (N = 91) | P | |
|---|---|---|---|---|
| Age | 49.7 ± 11.3 | 46.7 ± 10.3 | 45.3 ± 9.8 | 0.002 |
| BMI | 23.5 ± 3.4 | 22.8 ± 4.0 | 23.4 ± 3.2 | 0.761 |
| Stage | < 0.001 | |||
| 1A1 | 14 (9.9%) | 12 (15.6%) | 12 (13.2%) | |
| 1A2 | 10 (7.0%) | 2 (2.6%) | 1 (1.1%) | |
| 1B1 | 90 (63.4%) | 63 (81.8%) | 68 (74.7%) | |
| 1B2 | 28 (19.7%) | 0 | 10 (11.0%) | |
| Cell type | 0.157 | |||
| SCC | 106 (74.6%) | 58 (75.3%) | 60 (65.9%) | |
| AC | 32 (22.5%) | 18 (23.4%) | 31 (34.1%) | |
| AS | 4 (2.8%) | 1 (1.3%) | 0 |
ARH Abdominal radical hysterectomy, RRH Robotic radical hysterectomy, BMI Body mass index, SCC Squamous cell carcinoma, AC Adenocarcinoma, AS Adenosquamous